×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 7 (continued): Variations: The Role of Regulatory Affairs After Marketing Authorization
Session Chair(s)
Diptee A. Gajjar, PhD
Intercontinental Regulatory Strategy Lead
Bristol-Myers Squibb Company, United States
- Line extension
- Renewals
- Pharmacovigilance
- Postmarketing commitments
Have an account?